The lectin‐like domain of thrombomodulin is a drug candidate for both prophylaxis and treatment of liver ischemia and reperfusion injury in mice

MLA

Takeshi Watanabe, et al. “The Lectin‐like Domain of Thrombomodulin Is a Drug Candidate for Both Prophylaxis and Treatment of Liver Ischemia and Reperfusion Injury in Mice.” American Journal of Transplantation, vol. 21, no. 2, Feb. 2021, pp. 540–51. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5990f9da7cf2d94409dd805d371d5a50&authtype=sso&custid=ns315887.

APA

Takeshi Watanabe, Kenichi Saga, Hiroaki Terajima, Shinji Uemoto, Kentaro Kadono, Shugo Ueda, Yoichiro Uchida, Junya Kawasoe, Tomoyuki Miyauchi, & Hirofumi Hirao. (2021). The lectin‐like domain of thrombomodulin is a drug candidate for both prophylaxis and treatment of liver ischemia and reperfusion injury in mice. American Journal of Transplantation, 21(2), 540–551.

Chicago

Takeshi Watanabe, Kenichi Saga, Hiroaki Terajima, Shinji Uemoto, Kentaro Kadono, Shugo Ueda, Yoichiro Uchida, Junya Kawasoe, Tomoyuki Miyauchi, and Hirofumi Hirao. 2021. “The Lectin‐like Domain of Thrombomodulin Is a Drug Candidate for Both Prophylaxis and Treatment of Liver Ischemia and Reperfusion Injury in Mice.” American Journal of Transplantation 21 (2): 540–51. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5990f9da7cf2d94409dd805d371d5a50&authtype=sso&custid=ns315887.